Argenx
ARGX
#638
Rank
C$43.23 B
Marketcap
$722.96
Share price
-0.62%
Change (1 day)
4.41%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): -C$0.32 B

According to Argenx 's latest financial reports the company's current earnings (TTM) are -C$0.32 B. In 2023 the company made an earning of -C$0.42 B an increase over its 2022 earnings that were of -C$0.99 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.32 B-23.6%
2023 -C$0.42 B-58.25%
2022 -C$0.99 B
2019 -C$0.28 B125.05%
2018 -C$0.13 B132.12%
2017 -C$51.75 M55.01%
2016 -C$33.38 M32.9%
2015 -C$25.12 M13.58%
2014 -C$22.12 M46.29%
2013 -C$15.12 M